Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA.
Qiang ZhangZheng CaiLorenzo GerratanaAndrew A DavisPaolo D'AmicoAkhil ChawlaSaya L JacobYoubin ZhangJianhua JiaoWeijun QinGiancarlo FelicielloLisa FlaumAmi N ShahWilliam J GradisharPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Assessing the baseline levels of CTCs, CTC-clusters, and mutational ctDNA profile could reliably aid in differentiation of clinical stage and early prediction of metastasis and outcomes in advanced BCa.